Literature DB >> 26910514

Chemical synthesis of peptides within the insulin superfamily.

Fa Liu1, Alexander N Zaykov2, Jay J Levy2, Richard D DiMarchi2, John P Mayer2.   

Abstract

The synthesis of insulin has inspired fundamental advances in the art of peptide science while simultaneously revealing the structure-function relationship of this centrally important metabolic hormone. This review highlights milestones in the chemical synthesis of insulin that can be divided into two separate approaches: (i) disulfide bond formation driven by protein folding and (ii) chemical reactivity-directed sequential disulfide bond formation. Common to the two approaches are the persistent challenges presented by the hydrophobic nature of the individual A-chain and B-chain and the need for selective disulfide formation under mildly oxidative conditions. The extension and elaboration of these synthetic approaches have been ongoing within the broader insulin superfamily. These structurally similar peptides include the insulin-like growth factors and also the related peptides such as relaxin that signal through G-protein-coupled receptors. After a half-century of advances in insulin chemistry, we have reached a point where synthesis is no longer limiting structural and biological investigation within this family of peptide hormones. The future will increasingly focus on the refinement of structure to meet medicinal purposes that have long been pursued, such as the development of a glucose-sensitive insulin.
Copyright © 2016 European Peptide Society and John Wiley & Sons, Ltd. Copyright © 2016 European Peptide Society and John Wiley & Sons, Ltd.

Entities:  

Keywords:  bombyxin; insulin; insulin superfamily; insulin-like growth factor; insulin-like peptide; peptide synthesis; protein synthesis; relaxin

Mesh:

Substances:

Year:  2016        PMID: 26910514     DOI: 10.1002/psc.2863

Source DB:  PubMed          Journal:  J Pept Sci        ISSN: 1075-2617            Impact factor:   1.905


  7 in total

1.  Total Solid-Phase Synthesis of Biologically Active Drosophila Insulin-Like Peptide 2 (DILP2).

Authors:  Feng Lin; Mohammed Akhter Hossain; Stephanie Post; Galina Karashchuk; Marc Tatar; Pierre De Meyts; John D Wade
Journal:  Aust J Chem       Date:  2016-12-12       Impact factor: 1.321

2.  Chemically Precise Glycoengineering Improves Human Insulin.

Authors:  Xiaoyang Guan; Patrick K Chaffey; Xiuli Wei; Daniel R Gulbranson; Yuan Ruan; Xinfeng Wang; Yaohao Li; Yan Ouyang; Liqun Chen; Chen Zeng; Theo N Koelsch; Amy H Tran; Wei Liang; Jingshi Shen; Zhongping Tan
Journal:  ACS Chem Biol       Date:  2017-12-01       Impact factor: 5.100

3.  Glucose-responsive insulin by molecular and physical design.

Authors:  Naveed A Bakh; Abel B Cortinas; Michael A Weiss; Robert S Langer; Daniel G Anderson; Zhen Gu; Sanjoy Dutta; Michael S Strano
Journal:  Nat Chem       Date:  2017-09-22       Impact factor: 24.427

4.  A viral insulin-like peptide is a natural competitive antagonist of the human IGF-1 receptor.

Authors:  Fa Zhang; Emrah Altindis; C Ronald Kahn; Richard D DiMarchi; Vasily Gelfanov
Journal:  Mol Metab       Date:  2021-08-13       Impact factor: 8.568

5.  Insulin-like peptide 3 expressed in the silkworm possesses intrinsic disulfide bonds and full biological activity.

Authors:  Takatsugu Miyazaki; Masaaki Ishizaki; Hideo Dohra; Sungjo Park; Andre Terzic; Tatsuya Kato; Tetsuya Kohsaka; Enoch Y Park
Journal:  Sci Rep       Date:  2017-12-11       Impact factor: 4.379

Review 6.  Umpolung strategies for the functionalization of peptides and proteins.

Authors:  Andrew M White; Isabella R Palombi; Lara R Malins
Journal:  Chem Sci       Date:  2022-02-02       Impact factor: 9.825

Review 7.  Progress in Simulation Studies of Insulin Structure and Function.

Authors:  Biswajit Gorai; Harish Vashisth
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-20       Impact factor: 6.055

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.